Gilman Hill Asset Management, LLC Eli Lilly & CO Transaction History

Gilman Hill Asset Management, LLC

$594 Million
Q3 2024

A detailed history of Gilman Hill Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gilman Hill Asset Management, LLC holds 1,807 shares of LLY stock, worth $1.35 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

1,807

Previous 1,932 6.47%

Holding current value

$1.35 Million

Previous $1.75 Million 8.52%

% of portfolio

0.27%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$772.14 - $960.02 $96,517 - $120,002	-125 Reduced 6.47%	1,807 $1.6 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $637,160 - $799,046	-879 Reduced 31.27%	1,932 $1.75 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $820,197 - $1.1 Million	-1,385 Reduced 33.01%	2,811 $2.19 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $282,555 - $389,544	-650 Reduced 13.41%	4,196 $2.25 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $157,833 - $211,041	-450 Reduced 8.5%	4,846 $2.27 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $85,423 - $100,325	-275 Reduced 4.94%	5,296 $1.82 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $72,348 - $84,300	-225 Reduced 3.88%	5,571 $0
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $100,803 - $114,875	-340 Reduced 5.54%	5,796 $1.87 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $540,736 - $634,903	1,940 Added 46.23%	6,136 $1.99 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $88,008 - $109,372	-375 Reduced 8.2%	4,196 $1.2 Million
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $19,500 - $23,998	88 Added 1.96%	4,571 $1.06 Million
Q2 2021 Jul 16, 2021	SELL	$180.55 - $233.54 $18,416 - $23,821	-102 Reduced 2.22%	4,483 $1.03 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $6,572 - $8,508	-40 Reduced 0.86%	4,585 $857,000
Q3 2020 Oct 16, 2020	SELL	$146.22 - $169.13 $10,966 - $12,684	-75 Reduced 1.6%	4,625 $685,000
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $6,820 - $8,209	-50 Reduced 1.05%	4,700 $772,000
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $13,365 - $16,553	-125 Reduced 2.56%	4,750 $624,000
Q3 2019 Oct 18, 2019	SELL	$106.79 - $116.16 $1,067 - $1,161	-10 Reduced 0.2%	4,875 $545,000
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $89,604 - $105,471	-805 Reduced 14.15%	4,885 $634,000
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $71,482 - $80,082	-675 Reduced 10.6%	5,690 $658,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $45,420 - $52,128	600 Added 10.41%	6,365 $543,000
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $3,710 - $4,380	50 Added 0.87%	5,765 $446,000
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $440,455 - $488,861	5,715	5,715 $489,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.

Account

Gilman Hill Asset Management, LLC Eli Lilly & CO Transaction History